Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Nov 01, 2024

BUY
$22.0 - $69.71 $550,000 - $1.74 Million
25,000 New
25,000 $1.68 Million
Q2 2024

Aug 09, 2024

BUY
$22.0 - $69.71 $145,200 - $460,085
6,600 Added 35.87%
25,000 $1.68 Million
Q1 2024

May 09, 2024

BUY
$25.72 - $29.94 $473,248 - $550,896
18,400 New
18,400 $499,000
Q3 2023

Oct 27, 2023

BUY
$19.86 - $26.93 $212,502 - $288,151
10,700 New
10,700 $270,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.